✦ LIBER ✦

Rituximab and rapamycin for posttransplant lymphoproliferative disease treatment: report of three cases

✍ Scribed by V.D Garcia; J.S Bonamigo-Filho; J Neumann; L Fogliatto; A.M Gaiger; C.D Garcia; V Barros; E Keitel; A.E Bittar; A.F Santos; S Roithmann

Book ID: 117232702
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 57 KB
Volume: 34
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(02)03511-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab as Treatment of Posttransplant

Rituximab as Treatment of Posttransplant Lymphoproliferative Disorder in Patients Who Underwent Small Bowel/Multivisceral Transplantation: Report of Three Cases

✍ M. Codeluppi; S. Cocchi; G. Guaraldi; F. Di Benedetto; A. Bagni; M. Pecorari; W. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Case Report: Successful Treatment of Pos

Case Report: Successful Treatment of Posttransplant Lymphoproliferative Disorder and Quiescence of Dermatomyositis With Rituximab and Sirolimus

✍ Z. Kaposztas; W.B. Etheridge; B.D. Kahan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Low-Dose Chemotherapy and Rituximab for

Low-Dose Chemotherapy and Rituximab for Posttransplant Lymphoproliferative Disease (PTLD): A Children's Oncology Group Report

✍ T. G. Gross; M. A. Orjuela; S. L. Perkins; J. R. Park; J. C. Lynch; M. S. Cairo; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

Rituximab for myasthenia gravis: Three c

Rituximab for myasthenia gravis: Three case reports and review of the literature

✍ Karl Stieglbauer; Raffi Topakian; Viktoria Schäffer; Franz T. Aichner 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Rituximab for the treatment of refractor

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases

✍ Lydia Koulova; Doru Alexandrescu; Janice P. Dutcher; Kevin P. O'Boyle; Saji Eape 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Three patients (one with idiopathic thrombocytopenic purpura [ITP] and two with thrombotic thrombocytopenic purpura [TTP]) were treated with rituximab (anti-CD20 chimeric antibody) at a dose of 325 mg/m 2 administered weekly after they failed standard therapies. The patient with ITP who did not resp

Vacuum-Assisted Closure Therapy: A New T

Vacuum-Assisted Closure Therapy: A New Treatment Option for Recurrent Pilonidal Sinus Disease. Report of Three Cases

✍ Jenny B. Lynch; Alan J. Laing; Padraic J. Regan 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 105 KB